Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 15/20 | 0.46 |
| ▸ | NPY1R | P25929 | 8/20 | 0.46 |
| ▸ | NPY2R | P49146 | 6/20 | 0.46 |
| ▸ | NPY5R | Q15761 | 6/20 | 0.46 |
| ▸ | FURIN | P09958 | 2/20 | 0.43 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.43 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.42 |
| ▸ | TFPI | P10646 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30571037 | 0.90 | NPY4R (0.53) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL31433226 | 0.89 | TFPI (0.48) | FURINIL23RTFPI | |
| SCHEMBL31663916 | 0.88 | NPY4R (0.48) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30912345 | 0.88 | NPY4R (0.45) | NPY4RNPY1RNPY2RNPY5RFURIN | |
| SCHEMBL3459806 | 0.88 | NPY4R (0.55) | NPY4RNPY1RNPY2RNPY5RFURIN | |
| SCHEMBL3459809 | 0.88 | NPY4R (0.55) | NPY4RNPY1RNPY2RNPY5RFURIN | |
| SCHEMBL30881172 | 0.88 | NPY4R (0.55) | NPY4RNPY1RNPY2RNPY5RFURIN | |
| SCHEMBL30098797 | 0.88 | NPY4R (0.53) | NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL9843297 | 0.88 | NPY4R (0.46) | NPY4RNPY1RNPY2RNPY5RFURIN | |
| SCHEMBL31665975 | 0.88 | NPY4R (0.51) | NPY4RNPY1RNPY2RNPY5RFURIN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113773366-B | Anti-inflammatory polypeptide BMP14, and preparation method and application thereof | 四川丽妍工坊生物科技有限公司 | 2023-06-16 | — | — | CN | claimed |